Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madison C Garibotti

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Physiology. Cell Physiology|July 11, 2022
Mitochondrial stress responses in Duchenne muscular dystrophy: metabolic dysfunction or adaptive reprogramming?Catherine A Bellissimo, Madison C Garibotti, Christopher G R Perry
Redox Biology|August 23, 2024
Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20Meghan C Hughes, Sofhia V Ramos, Aditya N Brahmbhatt, et al.
American Journal of Physiology. Cell Physiology|December 25, 2023
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.<i>mdx</i> mouse model of Duchenne muscular dystrophyCatherine A Bellissimo, Shivam Gandhi, Laura N Castellani, et al.
The Journal of Physiology|November 3, 2025
The mitochondrial-targeted antioxidant SkQ1 prevents skeletal muscle mitochondrial-apoptotic but not necroptotic signalling during ovarian cancerShahrzad Khajehzadehshoushtar, Luca J Delfinis, Fasih A Rahman, et al.
JCI Insight|November 8, 2022
Muscle weakness precedes atrophy during cancer cachexia and is linked to muscle-specific mitochondrial stressLuca J Delfinis, Catherine A Bellissimo, Shivam Gandhi, et al.
The American Journal of Pathology|July 20, 2024
Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy PhenotypeLeslie M Ogilvie, Luca J Delfinis, Bridget Coyle-Asbil, et al.
Molecular Metabolism|June 26, 2024
Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexiaLuca J Delfinis, Leslie M Ogilvie, Shahrzad Khajehzadehshoushtar, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexiaLuca J Delfinis, Leslie M Ogilvie, Shahrzad Khajehzadehshoushtar, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in miceLuca J Delfinis, Shahrzad Khajehzadehshoushtar, Luke D Flewwelling, et al.
Molecular Metabolism|July 18, 2025
Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancerLuca J Delfinis, Shahrzad Khajehzadehshoushtar, Luke D Flewwelling, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Cell Physiology|July 11, 2022
Mitochondrial stress responses in Duchenne muscular dystrophy: metabolic dysfunction or adaptive reprogramming?Catherine A Bellissimo, Madison C Garibotti, Christopher G R Perry
Redox Biology|August 23, 2024
Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20Meghan C Hughes, Sofhia V Ramos, Aditya N Brahmbhatt, et al.
American Journal of Physiology. Cell Physiology|December 25, 2023
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.<i>mdx</i> mouse model of Duchenne muscular dystrophyCatherine A Bellissimo, Shivam Gandhi, Laura N Castellani, et al.
The Journal of Physiology|November 3, 2025
The mitochondrial-targeted antioxidant SkQ1 prevents skeletal muscle mitochondrial-apoptotic but not necroptotic signalling during ovarian cancerShahrzad Khajehzadehshoushtar, Luca J Delfinis, Fasih A Rahman, et al.
JCI Insight|November 8, 2022
Muscle weakness precedes atrophy during cancer cachexia and is linked to muscle-specific mitochondrial stressLuca J Delfinis, Catherine A Bellissimo, Shivam Gandhi, et al.
The American Journal of Pathology|July 20, 2024
Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy PhenotypeLeslie M Ogilvie, Luca J Delfinis, Bridget Coyle-Asbil, et al.
Molecular Metabolism|June 26, 2024
Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexiaLuca J Delfinis, Leslie M Ogilvie, Shahrzad Khajehzadehshoushtar, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexiaLuca J Delfinis, Leslie M Ogilvie, Shahrzad Khajehzadehshoushtar, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in miceLuca J Delfinis, Shahrzad Khajehzadehshoushtar, Luke D Flewwelling, et al.
Molecular Metabolism|July 18, 2025
Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancerLuca J Delfinis, Shahrzad Khajehzadehshoushtar, Luke D Flewwelling, et al.
Pageof 2